Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Inflammatory Bowel Diseases

Free Subscription 01.12.2025 3 Aliment Pharmacol Ther 3 Am J Gastroenterol 1 BMC Gastroenterol 4 Clin Gastroenterol Hepatol 3 Dig Dis Sci 3 Gastroenterology 7 Inflamm Bowel Dis 1 J Clin Gastroenterol 5 J Crohns Colitis 1 Lancet Gastroenterol Hepatol 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. SODERHOLM JD
   Editorial: The Appendix-A Dead End for Treating Ulcerative Colitis, After All?
   Aliment Pharmacol Ther. 2025 Nov 25. doi: 10.1111/apt.70370.
   PubMed        
   
   
2. DERKS MEW, Hoentjen F
   Editorial: High-Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer-Authors' Reply.
   Aliment Pharmacol Ther. 2025 Nov 24. doi: 10.1111/apt.70473.
   PubMed        
   
   
3. HICKEY A, Dong C, Lamb CA
   Editorial: High-Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer.
   Aliment Pharmacol Ther. 2025 Nov 24. doi: 10.1111/apt.70442.
   PubMed        
   
   

   
   Am J Gastroenterol

4. ARAKA E, Kahn-Boesel O, Lopes E, Ufere NN, et al
   Women and Younger Adults with Inflammatory Bowel Disease are at Greater Risk for Financial Toxicity from IBD.
   Am J Gastroenterol. 2025 Nov 18. doi: 10.14309/ajg.0000000000003847.
   PubMed         Abstract available
   
   
5. DUBINSKY M, Bleakman AP, Vavricka S, Travis S, et al
   Bowel Urgency in Crohn's Disease: Bridging the Gap Between Patients and Healthcare Providers.
   Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003858.
   PubMed         Abstract available
   
   
6. WINDSOR JW, Coward S, Hracs L, Mak JWY, et al
   TRENDS IN THE ULCERATIVE COLITIS TO CROHN'S DISEASE INCIDENCE RATIO ARE DISTINCT BETWEEN EPIDEMIOLOGIC STAGES OF INFLAMMATORY BOWEL DISEASE.
   Am J Gastroenterol. 2025 Nov 24. doi: 10.14309/ajg.0000000000003868.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. SHIRMARD FO, Pourfaraji SM, Omouri-Kharashtomi M, Amani A, et al
   Efficacy of GLP-1 receptor agonists on obesity and metabolic profile in patients with inflammatory bowel disease: a systematic review and meta-analysis.
   BMC Gastroenterol. 2025 Nov 22. doi: 10.1186/s12876-025-04496.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

8. HE Z, Sun Y, Huang H, Fu T, et al
   Circulating Metabolite Signatures Linking Physical Activity to Inflammatory Bowel Disease Risk and Interactions with Genetic Susceptibility.
   Clin Gastroenterol Hepatol. 2025 Nov 24:S1542-3565(25)00997.
   PubMed         Abstract available
   
   
9. KIM SH, Qi Y, Banegas MP, Kappelman MD, et al
   Prevalence and Impact of Social Risk in Patients With Inflammatory Bowel Diseases: National Estimates From the United States.
   Clin Gastroenterol Hepatol. 2025;23:2588-2596.
   PubMed         Abstract available
   
   
10. MATHIEU N, Hupe M, Heluwaert F, Riviere P, et al
    PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission.
    Clin Gastroenterol Hepatol. 2025;23:2597-2606.
    PubMed         Abstract available
    
    
11. DAMAS OM, Leo M, Colina N, Mijares M, et al
    A Pilot Randomized Control Trial to Assess the Adjunctive Effect of Diet on Response to Advanced Therapies in Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2025;23:2579-2587.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

12. LUO M, Li Z, Cai L, Bu S, et al
    A Rare Extraintestinal Manifestation of Ulcerative Colitis.
    Dig Dis Sci. 2025 Nov 23. doi: 10.1007/s10620-025-09562.
    PubMed        
    
    
13. ZHANG S, Gu Y
    Walking on a Tightrope: Ulcerative Colitis Complicated by Clostridioides difficile Infection.
    Dig Dis Sci. 2025 Nov 25. doi: 10.1007/s10620-025-09582.
    PubMed        
    
    
14. SATO T, Takeuchi J, Nagase K, Shiraishi T, et al
    Initial Treatment Failure as a Predictor of Proximal Extension in Patients with Newly Diagnosed Limited Ulcerative Colitis: A Retrospective Cohort Study with Propensity Score-Matched Analysis.
    Dig Dis Sci. 2025 Nov 28. doi: 10.1007/s10620-025-09561.
    PubMed         Abstract available
    
    

    
    Gastroenterology

15. CHEN MY, Onal G, Mukherjee A, Ayati A, et al
    A Response to "Heavy Metals and Inflammatory Bowel Disease" Using Linked Sources of Real-World Data.
    Gastroenterology. 2025 Nov 21:S0016-5085(25)06576.
    PubMed        
    
    
16. SCOTT FI, Ananthakrishnan AN, Click B, Agrawal M, et al
    AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.
    Gastroenterology. 2025;169:1397-1448.
    PubMed         Abstract available
    
    
17. JUKIC A, Hilbe R, Zundel L, Willeit P, et al
    Fecal Detection of Calprotectin Subunits Links Inflammatory Bowel Disease Activity With Chronicity of Intestinal Inflammation.
    Gastroenterology. 2025 Nov 26:S0016-5085(25)05987.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

18. SHOJAEI JESHVAGHANI Z, Argmann C, de Vries MH, van Es JH, et al
    A Collection of Patient-Derived Intestinal Organoid Lines Reveals Epithelial Phenotypes Associated with Genetic Drivers of Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 Nov 22:izaf296. doi: 10.1093.
    PubMed         Abstract available
    
    
19. VEMULAKONDA P, Stark VS, Deogaonkar A, Borum ML, et al
    Artificial Intelligence as a New Player in Dietary Management of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 Nov 22:izaf286. doi: 10.1093.
    PubMed        
    
    
20. KAKUTA Y, Li D, Debbas P, Okazaki S, et al
    Differences in Anti-alphavbeta6 Integrin Antibody Expression between U.S. and Japanese Cohorts in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 Nov 22:izaf246. doi: 10.1093.
    PubMed         Abstract available
    
    
21. FAYE AS, Rubin DT, Siegel CA, Long MD, et al
    Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age.
    Inflamm Bowel Dis. 2025 Nov 22:izaf258. doi: 10.1093.
    PubMed         Abstract available
    
    
22. WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
    Serum and Histologic Eosinophilia as a Predictive Biomarker of Response to Mirikizumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2025 Nov 24:izaf267. doi: 10.1093.
    PubMed         Abstract available
    
    
23. HABERMAN Y, Braun T, Karns R, Bartel CA, et al
    Short Ileal Microvillus Length Phenotype Associates with Progression from Inflammatory to Complicated Disease Behavior in Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2025 Nov 28:izaf288. doi: 10.1093.
    PubMed         Abstract available
    
    
24. MO X, Mo H, Wang C, Pu Q, et al
    Shared Genetic Basis Between Systemic Lupus Erythematosus and Inflammatory Bowel Disease in East Asian Ancestry: A Genome-Wide Cross-trait Analysis.
    Inflamm Bowel Dis. 2025 Nov 28:izaf297. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Clin Gastroenterol

25. XU X, Li W, Ling T, Lan X, et al
    Combined Endoscopic and Radiologic Approaches for Differentiating Inflammatory and Fibrotic Strictures in Crohn's Disease: A Comprehensive Diagnostic Strategy.
    J Clin Gastroenterol. 2025 Nov 25. doi: 10.1097/MCG.0000000000002294.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

26. WANG Y, Wang H, Wu X, Duan X, et al
    Development and validation of a novel multimodal deep learning model integrating histopathology, radiology, and clinical data to predict primary non-response to infliximab in patients with crohn's disease.
    J Crohns Colitis. 2025 Nov 26:jjaf206. doi: 10.1093.
    PubMed         Abstract available
    
    
27. LIM CT, Teichert C, Gecse K
    Beyond the Mucosa: Intestinal Ultrasound for Post Endoscopic Healing Risk Stratification in Ulcerative Colitis-Authors' Reply.
    J Crohns Colitis. 2025 Nov 25:jjaf199. doi: 10.1093.
    PubMed        
    
    
28. KATSOULA A, Paschos P, Malandris K, Kalogirou MS, et al
    Systematic Review and Network Meta-Analysis: Evaluating the Impact of advanced therapies for Moderate-to-Severe Ulcerative Colitis on Health-Related Quality of Life.
    J Crohns Colitis. 2025 Nov 24:jjaf210. doi: 10.1093.
    PubMed         Abstract available
    
    
29. MIGLIORISI G, Delaplace R, Honap S, Germain A, et al
    From Resection to Preservation: Redefining the Surgical Paradigm in Crohn's Disease.
    J Crohns Colitis. 2025 Nov 24:jjaf208. doi: 10.1093.
    PubMed         Abstract available
    
    
30. BOUWKNEGT DG, Hoekstra B, Donker HC, van Es B, et al
    How long is long enough? Timing of pre-conceptional remission predicts relapse risk during pregnancy in IBD.
    J Crohns Colitis. 2025;19:jjaf176.
    PubMed         Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

31. SHEBAB M, Al-Hindawi A, Goodwin SW, Yuan Y, et al
    Closing the Middle East and north Africa representation gap in clinical trials in inflammatory bowel disease.
    Lancet Gastroenterol Hepatol. 2025 Nov 25:S2468-1253(25)00346.
    PubMed        
    
    

    
    Scand J Gastroenterol

32. RAITIO A, Hukkinen M, Hyvarinen I, Nordin A, et al
    Risk of biliary cancer in Finnish patients with choledochal malformations: A population-based register study.
    Scand J Gastroenterol. 2025 Nov 9:1-6. doi: 10.1080/00365521.2025.2583936.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.